Genetically engineered models have advantages over xenografts for preclinical studies: Response

Cancer Research

Volumn 66, Issue 7, 2006, Pages 3358-3359

  Sausville, Edward A ^a   Burger, Angelika M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; ARSENIC; IMATINIB; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RETINOIC ACID;

CHRONIC MYELOID LEUKEMIA; GLIOBLASTOMA; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; XENOGRAFT;

EID: 33645733336     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)